Thymus-dependent membrane antigens in man: Inhibition of cell-mediated lympholysis by monoclonal antibodies to T _{H 2} antigen

Abstract

In prior studies a heteroantiserum to a surface membrane component termed TH2 was used to define two subsets ofhuman T cells (TH2 and TH ), which were found to express distinct sets of activities in vitra2In the present studies we prepared monoclonal antibodies to surface determinants that are restricted to T cells belonging to, each of these two subsets. Two antibodies, termed aLeu-2a and aLeu-2b, which seem to define the same surface antigen identified by the original T 2 antiserum reacted with 57-84% of thymocytes and 22-46% oP the erythrocyte-rosette-forming cells (ERF-C) in peripheral blood. Two other monoclonal antibodies, termed aLeu-3a and atLeu-3b, reacted with the same subpopulation of thymocytes (78-89%) and peripheral blood ERF-C (47-78%) but, unlike aLeu-2a and aLeu-2b, did not exhibit cross-blocking; i.e., labeling cells with aLeu-3a did not inhibit the subsequent binding of aLeu-3b. T cells reactive with aLeu-2a were shown to be unreactive with aLeu-3a, indicating that two separate subpopulations of T cells, Leu-2 (formerly TH2 ) and (TH2-) T cells, were thereby defined. These two T cell subsets make up the subpopulation of ERF-C (80-95%) previously defined by a monoclonal antibody to a T cell membrane antigen (Leu-1) that has a thymus-dependent distribution on normal lymphocytes but is expressed by some surface-immunoglobulin-positive (sIg') leukemic lymphocytes. None of the Leu antibodies reported here reacted with sIg', Leu-1I leukemic cells, nor did they react with normal hematopoietic cells or lymphoid cells that had surface markers characteristic of B cells. Studies of the blocking effects of Leu antibodies on killing in cell-mediated lympholysis by effector T cells were carried out in the absence ofcomplement. These experiments established the following points: (i) aLeu-2a abolished the killing by cytotoxic T cells of allogeneic phytohemagglutinin-stimulated blasts, (ii) inhibition of killing by aLeu-2b was markedly less than inhibition by aLeu-2a, and (iii) other antibodies, including aLeu-1, aLeu-3a, and aLeu-3b, had little or no effect on killing in cell-mediated lympholysis. The relevance of these findings to prior studies done in the mouse and -in man are discussed.There is now good evidence in man, as in the mouse, that the thymus gives rise to functionally distinct subpopulations of T cells that can be defined by their unique surface phenotypes of thymus-dependent membrane antigens (1-7). This was demonstrated by the use of heterologous anti-human T cell sera (6, 7) and has been explored more recently by using monoclonal antibodies generated by somatic cell hybridization techniques (8,9). These studies have shown that a thymus-dependent antigen, termed TH2, is expressed on 30-40% of circulating T cells, and that TH2+ T cells mediate suppressor effects in vitro and are also responsible for most of the killing in cell-mediated lympholysis (CML) (7, 9). In contrast, TH2-T cells were shown to effect markedly less cytotoxic activity in CML but were found to amplify the functions...

Sustained improvement of intractable rheumatoid arthritis after total lymphoid irradiation

“…A fluoresciin-conjugated goat anti-mouse IgG antibody (Tago, Burlingame, CA) was used as a second stage reagent. Previous studies have shown that Leu-4 antigen identifies all T cells, Leu-2 antigen identifies the suppressor/cytotoxic subset, and Leu-3 antigen identifies the helperhnducer subset (39,42,43).…”

“…The absolute lymphocyte count was determined by multiplying the total white blood cell count by the percent of lymphocytes. PBM were stained with murine monoclonal antibodies using a two-step procedure, and analyzed with a vated cell sorter (FACS-111) as previously riefly, murine monoclonal antibodies to the human Leu-2, Leu-3, and Leu-4 lymphocyte surface antigens were produced by the somatic cell hybridization method (42). Supernatants from cloned cell lines (kindly provided by Dr. Robert Evans of the Memorial Sloan Kettering Institute,, New York) were used as first stage reagents.…”

The cellular content of non Hodgkin lymphomas: A comprehensive analysis using monoclonal antibodies and other surface marker techniques

“…aLeu-3a Clone SK3, an IgGI antibody defining a 55K MW antigen present upon T cells mediating PWM-induced B cell antibody synthesis (Evans et al, 1981).…”

The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients.

“…Mouse mAbs were used for the identification of specific cell types . Leu-1, Leu-2a, and Leu-3a (11,12) (anti -T cells and their subsets) and Leu-M5 (anti-monocyte/macrophage) (13) were obtained from Becton Dickinson & Co., Mountain View, CA .…”